Annual Total Liabilities
$28.46 M
-$1.52 M-5.07%
December 31, 2023
Summary
- As of February 12, 2025, CADL annual total liabilities is $28.46 million, with the most recent change of -$1.52 million (-5.07%) on December 31, 2023.
- During the last 3 years, CADL annual total liabilities has fallen by -$33.39 million (-53.99%).
- CADL annual total liabilities is now -53.99% below its all-time high of $61.84 million, reached on December 31, 2020.
Performance
CADL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$36.77 M
+$317.00 K+0.87%
September 30, 2024
Summary
- As of February 12, 2025, CADL quarterly total liabilities is $36.77 million, with the most recent change of +$317.00 thousand (+0.87%) on September 30, 2024.
- Over the past year, CADL quarterly total liabilities has increased by +$317.00 thousand (+0.87%).
- CADL quarterly total liabilities is now -50.25% below its all-time high of $73.92 million, reached on June 30, 2021.
Performance
CADL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CADL Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.1% | +0.9% |
| 3 y3 years | -54.0% | +22.7% |
| 5 y5 years | -47.2% | +22.7% |
CADL Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.1% | +13.5% | -2.7% | +46.7% |
| 5 y | 5-year | -54.0% | +13.5% | -50.3% | +46.7% |
| alltime | all time | -54.0% | +13.5% | -50.3% | +46.7% |
Candel Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.77 M(+0.9%) |
| Jun 2024 | - | $36.46 M(+44.5%) |
| Mar 2024 | - | $25.24 M(-11.3%) |
| Dec 2023 | $28.46 M(-5.1%) | $28.46 M(+5.2%) |
| Sep 2023 | - | $27.04 M(-3.2%) |
| Jun 2023 | - | $27.94 M(+1.3%) |
| Mar 2023 | - | $27.59 M(-8.0%) |
| Dec 2022 | $29.98 M | $29.98 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $32.88 M(-1.1%) |
| Jun 2022 | - | $33.23 M(-12.1%) |
| Mar 2022 | - | $37.80 M(+50.8%) |
| Dec 2021 | $25.07 M(-59.5%) | $25.07 M(-24.0%) |
| Sep 2021 | - | $32.97 M(-55.4%) |
| Jun 2021 | - | $73.92 M(+18.1%) |
| Mar 2021 | - | $62.59 M(+1.2%) |
| Dec 2020 | $61.84 M(+14.7%) | $61.84 M |
| Dec 2019 | $53.94 M | - |
FAQ
- What is Candel Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Candel Therapeutics?
- What is Candel Therapeutics annual total liabilities year-on-year change?
- What is Candel Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Candel Therapeutics?
- What is Candel Therapeutics quarterly total liabilities year-on-year change?
What is Candel Therapeutics annual total liabilities?
The current annual total liabilities of CADL is $28.46 M
What is the all time high annual total liabilities for Candel Therapeutics?
Candel Therapeutics all-time high annual total liabilities is $61.84 M
What is Candel Therapeutics annual total liabilities year-on-year change?
Over the past year, CADL annual total liabilities has changed by -$1.52 M (-5.07%)
What is Candel Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CADL is $36.77 M
What is the all time high quarterly total liabilities for Candel Therapeutics?
Candel Therapeutics all-time high quarterly total liabilities is $73.92 M
What is Candel Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CADL quarterly total liabilities has changed by +$317.00 K (+0.87%)